Triple antithrombotic therapy after percutaneous coronary intervention (PCI) in patients with indication for oral anticoagulation: Data from a single center registry

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Staudacher, Dawid L ^a   Kaiser, Michael ^a   Hehrlein, Christoph ^a   Bode, Christoph ^a   Ahrens, Ingo ^a   Merx, Marc W ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b KRH Robert Koch Klinikum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PHENPROCOUMON; PROTON PUMP INHIBITOR; TROPONIN T; FIBRINOLYTIC AGENT;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BLEEDING; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG ELUTING STENT; DRUG RESPONSE; HEART INFARCTION; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; TREATMENT DURATION; ADVERSE EFFECTS; FEMALE; FIBRINOLYTIC THERAPY; PROCEDURES; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOEMBOLISM; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84947791689     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140101     Document Type: Article

References (14)

1. Rubboli A, Bolognese L, Di Pasquale G, Galvani M, La Vecchia L, Maggioni A.P. (2009) A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry. J Cardiovasc Med (Hagerstown) 10: 200-203.
2. Rossini R, Musumeci G, Lettieri C, Molfese M., Mihalcsik L, Mantovani P, et al (2008) Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy. Am J Cardiol 102:1618-1623. doi: 10.1016/j.amjcard.2008.08.021 PMID: 19064015
3. Connolly S, Pogue J, Hart R., Pfeffer M, Hohnloser S, Chrolavicius S., et al. (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 367:1903-1912. PMID: 16765759
4. Hamm CW, Bassand JP, Agewall S, Bax J., Boersma E, Bueno H, et al (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32: 2999-3054. doi: 10.1093/eurheartj/ehr236 PMID: 21873419
5. O'Gara P.T., Kushner FG, Ascheim D.D., Casey DE, Chung MK, de Lemos JA, et al. (2013) 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127: 529-555. doi: 10.1161/CIR.0b013e3182742c84 PMID: 23247303
6. Hansen ML, Sorensen R, Clausen M.T., Fog-Petersen ML, Raunso J, Gadsboll N., et al. (2010) Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med 170:1433-1441. doi: 10.1001/archinternmed.2010.271 PMID: 20837828
7. Abraham NS, Hartman C, Richardson P., Castillo D, Street RL Jr., Naik AD (2013) Risk of lower and upper gastrointestinal bleeding, transfusions, and hospitalizations with complex antithrombotic therapy in elderly patients. Circulation 128:1869-1877. doi: 10.1161/CIRCULATIONAHA.113.004747 PMID: 24025594
8. Sorensen R, Hansen ML, Abildstrom S.Z., Hvelplund A., Andersson C, Jorgensen C, et al (2009) Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. Lancet 374:1967-1974. doi: 10.1016/S0140-6736(09)61751-7 PMID: 20006130
9. Subherwal S, Bach RG, Chen A.Y., Gage BF, Rao SV, Newby L.K., et al. (2009) Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation 119:1873-1882. doi: 10.1161/CIRCULATIONAHA.108. 828541 PMID: 19332461
10. Apostolakis S, Lane DA, Guo Y, Buller H., Lip G.Y. (2012) Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocou-marol in patients with atrial fibrillation) study. J Am Coll Cardiol 60: 861-867. doi: 10.1016/j.jacc.2012. 06.019 PMID: 22858389
11. Lip GY, Frison L, Halperin J.L., Lane D.A. (2011) Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol 57:173-180. doi: 10.1016/j.jacc.2010.09.024 PMID: 21111555
12. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip G.Y. (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138:1093-1100. doi: 10.1378/chest.10-0134 PMID: 20299623
13. Lip GY, Nieuwlaat R, Pisters R., Lane DA, Crijns H.J. (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137: 263-272. doi: 10.1378/chest.09-1584 PMID: 19762550
14. Dewilde WJ, Oirbans T, Verheugt F.W., Kelder JC, De Smet BJ, Herrman JP, et al. (2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 381:1107-1115. doi: 10.1016/S0140-6736(12)62177-1 PMID: 23415013